Michel Lagarde
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michel Lagarde
Michel Lagarde is recorded as Board Member and CEO at West Pharmaceutical Services Inc (WST). West Pharmaceutical Services Inc reported in an 8-K filed June 1, 2026 that Michel Lagarde was appointed member of the Board, effective August 31, 2026. West Pharmaceutical Services Inc reported in an 8-K filed June 1, 2026 that Michel Lagarde was appointed President and Chief Executive Officer, effective August 31, 2026.
“As of the Start Date, Mr. Green will resign as a member of the Board and Mr. Lagarde will be appointed as a member of the Board to fill that vacancy.”
“On June 1, 2026, the Company announced the appointment of Michel Lagarde as President and Chief Executive Officer of the Company, effective August 31, 2026 (the "Start Date"), to replace Mr. Green in those roles.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-08-31–present
-
Current
2026-08-31–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at West Pharmaceutical Services Inc
Other people whose current roles at this company are on record from its filings.
- Robert F. Friel Chairman, Board Member
- Kimberly Banks MacKay General Counsel
- Chad R. Winters Chief Accounting Officer
- CURRENT Merus N.V Board Member
- Deborah L. V. Keller Board Member
- Douglas A. Michels Board Member
- Janet Haugen Board Member
- Mark A. Buthman Board Member
- Molly E. Joseph Board Member
- Molly Joseph Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.